On the West Coast, Lynnwood, Washington residents have many health-conscious options. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly, approved since 2022. Weight Method offers a separate telehealth program: licensed Washington providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for Lynnwood starts at $329/month, including the provider evaluation, the medication, ongoing care, and home delivery.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Lynnwood is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Lynnwood, WA. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
For many people in Lynnwood, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2022 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to Lynnwood.
Suburban life around Lynnwood comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide therapy addresses biology involved in weight regulation by reducing hunger signals, so Lynnwood area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month, delivered to your door. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.